All NewsFDA BriefsOncology IconsSpecial ReportsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPivotal Practice Views with the Oncology BrothersPodcastsPrecision MedicineSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Biomarker-Driven Lung Cancer
  • GIST
  • HER2 Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Small Cell Lung Cancer
  • Renal Cell Carcinoma
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE
Advertisement

A 68-Year-Old Man With Mantle Cell Lymphoma

home / case-based-peer-perspectives / a-68-year-old-man-with-mantle-cell-lymphoma

Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.

Case Assessment: 68-Year-Old Patient With MCL

EP. 1: Case Assessment: 68-Year-Old Patient With MCL

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

Diagnosing MCL and Making Informed Treatment Decisions

EP. 2: Diagnosing MCL and Making Informed Treatment Decisions

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

Initiating Therapy for Mantle Cell Lymphoma

EP. 3: Initiating Therapy for Mantle Cell Lymphoma

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

Relapsed Mantle Cell Lymphoma Treatment Landscape

EP. 4: Relapsed Mantle Cell Lymphoma Treatment Landscape

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

Administration of BTK Inhibitors for Mantle Cell Lymphoma

EP. 5: Administration of BTK Inhibitors for Mantle Cell Lymphoma

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

BTK Inhibitor Toxicities in Mantle Cell Lymphoma

EP. 6: BTK Inhibitor Toxicities in Mantle Cell Lymphoma

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data

EP. 7: BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

Next Steps in Relapsed/Refractory Mantle Cell Lymphoma

EP. 8: Next Steps in Relapsed/Refractory Mantle Cell Lymphoma

Jonathon B. Cohen, MD, MS
May 18th 2020

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2024 MJH Life Sciences

All rights reserved.